According to Acumen Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$8.86. In 2022 the company made an earnings per share (EPS) of -HK$8.24 an increase over its 2021 EPS that were of -HK$20.95.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$8.93 | 8.41% |
2022 | -HK$8.24 | -60.67% |
2021 | -HK$20.95 | 954.24% |
2020 | -HK$1.99 |